Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis
- PMID: 26451982
- PMCID: PMC4603608
- DOI: 10.12659/MSM.894625
Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis
Abstract
Background: Many studies have reported that the p53 codon 72 polymorphism is associated with acute myeloid leukemia (AML) susceptibility; however, the conclusions are inconsistent. Therefore, we performed this meta-analysis to obtain a more precise result.
Material and methods: We searched PubMed to identify relevant studies, and 6 published case-control studies were retrieved, including 924 AML patients and 3832 controls. Odds ratio (OR) with corresponding 95% confidence interval (95%CI) was applied to assess the association between p53 codon 72 polymorphism and AML susceptibility. The meta-analysis was performed with Comprehensive Meta-Analysis software, version 2.2.
Results: Overall, no significant association between p53 codon 72 polymorphism and AML susceptibility was found in this meta-analysis (Pro vs. Arg: OR=0.94, 95%CI=0.81-1.10; Pro/Pro vs. Arg/Arg: OR=0.93, 95%CI=0.71-1.22; Arg/Pro vs. Arg/Arg: OR=0.79, 95%CI=0.55-1.13; (Pro/Pro + Arg/Pro) vs. Arg/Arg: OR=0.84, 95%CI=0.62-1.13; Pro/Pro vs. (Arg/Arg + Arg/Pro): OR=1.06, 95%CI=0.83-1.35). Similar results were also found in stratified analysis according to ethnicity and source of controls.
Conclusions: Our meta-analysis demonstrates that p53 codon 72 polymorphism may not be a risk factor for AML, which should be verified in future studies.
Figures




Similar articles
-
The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis.Medicine (Baltimore). 2015 Sep;94(38):e1588. doi: 10.1097/MD.0000000000001588. Medicine (Baltimore). 2015. PMID: 26402821 Free PMC article.
-
No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.Breast Cancer Res Treat. 2011 Jan;125(1):201-5. doi: 10.1007/s10549-010-0920-1. Epub 2010 May 23. Breast Cancer Res Treat. 2011. PMID: 20496166
-
Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.Arch Med Res. 2009 Oct;40(7):625-34. doi: 10.1016/j.arcmed.2009.09.004. Arch Med Res. 2009. PMID: 20082880
-
P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.Tumour Biol. 2013 Oct;34(5):2961-9. doi: 10.1007/s13277-013-0859-z. Epub 2013 May 30. Tumour Biol. 2013. PMID: 23715779
-
P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature.Int J Cancer. 2007 Oct 1;121(7):1481-6. doi: 10.1002/ijc.22833. Int J Cancer. 2007. PMID: 17546594 Review.
Cited by
-
Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis.Onco Targets Ther. 2016 Apr 20;9:2403-8. doi: 10.2147/OTT.S104181. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143935 Free PMC article.
-
Promiscuous Ribozymes and Their Proposed Role in Prebiotic Evolution.Chem Rev. 2020 Jun 10;120(11):4879-4897. doi: 10.1021/acs.chemrev.9b00620. Epub 2020 Feb 3. Chem Rev. 2020. PMID: 32011135 Free PMC article. Review.
-
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9. Biomark Res. 2024. PMID: 39538363 Free PMC article. Review.
-
Upregulation of Leukocytic Syncytin-1 in Acute Myeloid Leukemia Patients.Med Sci Monit. 2016 Jul 9;22:2392-403. doi: 10.12659/msm.899303. Med Sci Monit. 2016. PMID: 27393911 Free PMC article.
References
-
- Ye XH, Bu ZB, Feng J, et al. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep. 2014;41:373–85. - PubMed
-
- Zhou X, Gu Y, Zhang SL. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev. 2012;13:4909–14. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous